aureus by IgG antibodies, which helps immune cells to kill Staph, is key to offering protection. In this study we propose ...

aureus by IgG antibodies, which help immune cells to kill Staph, is key to offering protection. In this study, we propose ...

and the other is a fully proprietary next-generation immunoglobulin M (IgM) platform technology, Enhanced & Engineered Pentamer Body (ePendy). IMB-101 reduces inflammatory cytokines through ...

摘要支气管扩张症（简称支扩）是一种异质性很强的慢性气道疾病，其病因诊断对于疾病管理具有重要作用。中国支气管扩张症临床诊治与研究联盟、中华医学会呼吸病学分会感染学组组织专家，充分评估了支扩病因诊断领域最新的研究结果，基于国际通用的Delphi程序，经过 ...

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM ...

易栓症根据病因分为遗传性易栓症和获得性易栓症。遗传性易栓症的病因有明显的种族差异，在汉族人群中，遗传性易栓症的常见病因是蛋白C、蛋白S和抗凝血酶缺乏；遗传性易栓症是血栓栓塞性疾病比较明确的高危因素，与不良妊娠结局的关系一直存在争议，对胎盘源性疾病的发 ...

IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced a strategic pivot and pipeline transformation to accelerate and deepen its ...

IGM Biosciences (NASDAQ:IGMS – Free Report) had its price objective increased by Royal Bank of Canada from $17.00 to $20.00 in a research note published on Friday morning, Benzinga reports. Royal Bank ...

On Tuesday, IGM Biosciences Inc. (NASDAQ:IGMS) announced a strategic pivot and pipeline transformation to accelerate and deepen its leadership in developing T cell-engaging IgM antibodies for ...

Objectives Sjögren’s disease (SD) is an autoimmune disease affecting the exocrine glands that is associated with autoantibodies against Ro60/SS-A, anti-Ro52/TRIM21, La/SS-B and others. We examined the ...

A new study has found that low levels of one anti-inflammatory antibody — IgM anti-PC — are also associated with atherosclerosis and heart attacks in older women, while higher levels appear to ...